Home Featured

Featured

Intel-Mobileye Begin Testing AV Fleet in Jerusalem

ME Staff - May 17, 2018

Here’s What’s Moving Antares Pharma, Inc. (NASDAQ:ATRS) And Infinity Pharmaceuticals, Inc. (NASDAQ: INFI)

BioMarin, Sarepta’s Loss Could Be PTC’s Gain

A Cautionary Tale: Double-Check Your Option Orders

Cannabis Stock News Daily Roundup April 17

Biotech Movers: Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB) and Halozyme Therapeutics, Inc. (NASDAQ:HALO)

ME Contributor - September 15, 2017

Here’s What’s Moving Seattle Genetics, Inc. (NASDAQ:SGEN) and Heron Therapeutics, Inc....

ME Contributor - November 13, 2017

Here’s All You Need To Know About Seattle Genetics, Inc.’s (NASDAQ:SGEN)...

ME Contributor - May 26, 2016

Biotech Movers: Gemphire Therapeutics Inc. (NASDAQ:GEMP) and Moleculin Biotech, Inc., (NASDAQ:MBRX)

ME Contributor - June 29, 2017

Canopy Rivers Gets Approval to Expand Ontario’s Production Facility

ME Staff - August 11, 2019

Market Morning: Tariffs Come Into Force, More Bitcoin ETFs Bite Dust,...

ME Staff - August 23, 2018

What Is Sunovion Getting From The Cynapsus Therapeutics Inc (NASDAQ:CYNA) Deal?

ME Contributor - September 1, 2016

Celgene Corporation (NASDAQ:CELG) Kicks Off J.P. Morgan With A Bang

ME Contributor - January 8, 2018

Here’s What Really Just Happened With Dermira, Inc. (NASDAQ:DERM)

ME Contributor - March 6, 2018

Why Pluristem Therapeutics Inc. Is So Undervalued – The Market Is...

Rafi Farber - November 3, 2016

1 234...134 Page 3 of 134

/* */

EDITOR PICKS

Market Morning: S&P Says More Spending, Hong Kong Ping Pong, Riots,...

June 1, 2020

Market Morning: Moderna Miracle? Autos Fly On Lockdown Easing, NY Governor...

May 18, 2020

Market Morning: London Legalizes Moving, Congress and Fed Want More Spending,...

May 13, 2020

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.